Mobilising ECM to support Covid-19 healthcare equipment production - BNP Paribas CIB
 
Tuesday 12 May 2020

German medical technology manufacturer Drägerwerk turns to the equity capital markets to finance increase in Covid-19 ventilator production.


Drägerwerk AG & Co KGaA, a German manufacturer of medical technology (e.g. ventilators, anaesthesia devices, patient monitors, etc.) as well as safety technology products (e.g. face masks), has issued one million new preference shares in the equity capital markets to raise €76.5 million. Proceeds from the capital increase will be used to support the scaling up of production during the Covid-19 pandemic and to strengthen the equity base and liquidity.

The shares were offered in a private placement to institutional investors and the transaction was multiple times oversubscribed, highlighting the role investors are playing in supporting corporates during the coronavirus crisis. BNP Paribas Global Banking teams supported Drägerwerk throughout the book-building process, acting as joint global coordinator. 
" The capital increase will be used to support the scaling up of production during the Covid-19 pandemic and to strengthen the equity base and liquidity. "

Given the company's vital role in producing and maintaining critical healthcare infrastructure, Drägerwerk has seen a 177% increase of orders (net of currency effects) in its medical division in Q1 2020 vs Q1 2019. In light of the high order intake resulting from the Covid-19 pandemic, accessing the equity markets for fresh capital has been an important financial lever to address the current situation.

Drägerwerk's state-of-the-art factory in Lübeck, combined with flexible working hours and innovative labour organisation models, have allowed the firm to significantly increase output of ventilators.

According to the World Health Organisation, there are over 3.5 million confirmed coronavirus cases globally, as of 5 May 2020.






 

6
5
5
5
 
 

Give us your feedback

Please validate CAPTCHA.

RELATED ARTICLES
world-s-largest-social-bonds-support-eu-covid-19-response

The EU has issued €17bn in social bonds to help finance member states' programmes on employment support in the midst of the ongoing Covid-19 pandemic.

everything-you-ever-wanted-to-know-about-ipos-but-were-afraid-to-ask
The Initial Public Offering: What are IPOs? Why do they matter? Is the pain worth the gain?...
The Initial Public Offering: What are IPOs? Why do they matter? Is the pain worth the gain? Roger Barb,...
euromoney-recognises-bnp-paribas-investment-banking-expertise
The bank has been recognised for supporting clients throughout the Covid-19 crisis. Our experts explain...
The bank has been recognised for supporting clients throughout the Covid-19 crisis. Our experts explain their adapted approach...
bnp-paribas-wins-12-categories-at-global-capital-bond-awards-2020
BNP Paribas wins 12 categories at Global Capital Bond Awards, including Most Impressive Bank for Corporate...
BNP Paribas wins 12 categories at Global Capital Bond Awards, including Most Impressive Bank for Corporate Bonds,...
the-us-presidential-race-the-markets-big-tech-and-tax
Americans will vote following a Presidential election campaign unlike any other. The results have major...
Americans will vote following a Presidential election campaign unlike any other. The results have major market ramifications...
close
{POPUP_CONTENT}